Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Exercise tolerance decreased, Heart rate increased, Heart rate irregular, Impaired driving ability, Impaired work ability
Clinical narrative: POTS; autoimmune, autonomic, and neurological diseases; autoimmune, autonomic, and neurological diseases; autoimmune, autonomic, and neurological diseases; This initial spontaneous report was received from a lawyer and the consumer regarding a case in litigation and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported.   On unspecified dates, the patient received dose 1, 2 and 3 of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) administered as prophylaxis (strength, dose description, lot #, expiry date, and route of administration were not provided). Plaintiff was 21 years years old when she received her first dosage of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  On an unknown date, following her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccinations, Plaintiff began to suffer abdominal pain, dizziness, loss of appetite, and irregular heart rate. As the months progressed, so did Plaintiff's injuries. She was seen by multiple physicians and specialists for her complaints which now included: abdominal pain, rapid heart rate, dizziness, no appetite, fainting, and tingling in extremities. As a result of her post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, Plaintiff had been unable to engage in activities that a normal young person would enjoy. She has been unable to work, engage in any strenuous exercise, and her condition had impacted her ability to drive a car. Based upon her chronic and severe post-Gardasil symptoms, Plaintiff has been diagnosed with various medical conditions, including but not limited to, Postural orthostatic tachycardia syndrome (POTS). As previously discussed, the medical literature has documented other patients who, like Plaintiff, had suffered serious autoimmune, autonomic, and neurological dysfunctions, and who experienced similar side effects as those Plaintiff has suffered, and who were diagnosed with Gardasil-induced autoimmune, autonomic, and neurological diseases. As a proximate result of Merck's wrongful acts and omissions and its negligent and fraudulent testing, labeling, manufacturing, marketing and promotion of Gardasil, Plaintiff had suffered and continues to suffer severe and permanent physical injuries, and associated symptomology and has suffered severe and permanent emotional injuries, including pain and suffering. Plaintiff also has a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). The outcome of the events was reported as not recovered.  The causality between quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and the events was reported as related. The reporter considered the events to be disabling.   Upon internal review, autoimmune disorder was determined to be a medically significant event.